[Clinical course and differential diagnosis of thrombotic microangiopathy].

about

[Clinical course and differential diagnosis of thrombotic microangiopathy].

Item

http://www.wikidata.org/entity/Q52995556

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@en

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@nl

type

Item

label

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@en

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@nl

prefLabel

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@en

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@nl

P1476

[Clinical course and differential diagnosis of thrombotic microangiopathy].

@en

P2093

M Guthoff

http://www.w3.org/2001/XMLSchema#string

N Heyne

http://www.w3.org/2001/XMLSchema#string

P2860

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.

Thrombotic microangiopathies: multimers, metalloprotease, and beyond.

How I treat patients with thrombotic thrombocytopenic purpura: 2010.

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

P2888

s00063-016-0193-5

P31

scholarly article

P356

10.1007/S00063-016-0193-5

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27405938

http://www.w3.org/2001/XMLSchema#string